http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3373328

Outgoing Links

Predicate Object
contentType Journal Article|Review
endingPage 46
issn 2688-2663
issueIdentifier 1
pageRange 35-46
publicationName MedComm
startingPage 35
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_70abf1ffb7b93a873efff855532f08ab
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
bibliographicCitation Cai L, Xu J, Yang Z, Tong R, Dong Z, Wang C, Leong KW. Engineered biomaterials for cancer immunotherapy. MedComm (2020). 2020 Jun;1(1):35–46. PMID: 34766108; PMCID: PMC8489675.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_acd1834d6ac1681d9b813c516aafa12e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ad170f352c250c92b03f8dc74f66e5c4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_165037efeb143acc36a6f3cd87f0c74f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f50dc1d3c70ed45f75a3953f0d0e82e0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5b31b7ef00d45c7fa1da994436613c47
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aeb5f6fae082418375edd29db6d110c2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa10c2d92a3a45614d064f0ddfc43af3
date 2020-05-27^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/34766108
https://pubmed.ncbi.nlm.nih.gov/PMC8489675
https://doi.org/10.1002/mco2.8
isPartOf https://portal.issn.org/resource/ISSN/2688-2663
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/49834
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Engineered biomaterials for cancer immunotherapy

Showing number of triples: 1 to 27 of 27.